These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18484494)

  • 1. Comparison of the ability of various pharmaceutical silicates to amorphize and enhance dissolution of indomethacin upon co-grinding.
    Bahl D; Hudak J; Bogner RH
    Pharm Dev Technol; 2008; 13(3):255-69. PubMed ID: 18484494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism.
    Bahl D; Bogner RH
    Pharm Res; 2006 Oct; 23(10):2317-25. PubMed ID: 16927179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amorphization alone does not account for the enhancement of solubility of drug co-ground with silicate: the case of indomethacin.
    Bahl D; Bogner RH
    AAPS PharmSciTech; 2008; 9(1):146-53. PubMed ID: 18446475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-step continuous extrusion process for the manufacturing of solid dispersions.
    Maniruzzaman M; Nair A; Scoutaris N; Bradley MS; Snowden MJ; Douroumis D
    Int J Pharm; 2015 Dec; 496(1):42-51. PubMed ID: 26403386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amorphization of itraconazole by inorganic pharmaceutical excipients: comparison of excipients and processing methods.
    Grobelny P; Kazakevich I; Zhang D; Bogner R
    Pharm Dev Technol; 2015 Jan; 20(1):118-27. PubMed ID: 25312240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.
    Vadher AH; Parikh JR; Parikh RH; Solanki AB
    AAPS PharmSciTech; 2009; 10(2):606-14. PubMed ID: 19444620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs.
    Mura P; Valleri M; Cirri M; Mennini N
    Pharm Dev Technol; 2012; 17(3):277-84. PubMed ID: 21108583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
    Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
    Int J Pharm; 2018 Jun; 544(1):172-180. PubMed ID: 29669257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Specific Surface Area of Chitin-Metal Silicate Coprocessed Excipient on the Chemical Decomposition of Cefotaxime Sodium.
    Al-Nimry SS; Alkhamis KA; Alzarieni KZ
    J Pharm Sci; 2017 Feb; 106(2):570-578. PubMed ID: 27887722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex effects of drug/silicate ratio, solid-state equivalent pH, and moisture on chemical stability of amorphous quinapril hydrochloride coground with silicates.
    Hailu SA; Bogner RH
    J Pharm Sci; 2011 Apr; 100(4):1503-15. PubMed ID: 24081473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manufacture and performance evaluation of a stable amorphous complex of an acidic drug molecule and Neusilin.
    Maclean J; Medina C; Daurio D; Alvarez-Nunez F; Jona J; Munson E; Nagapudi K
    J Pharm Sci; 2011 Aug; 100(8):3332-3344. PubMed ID: 21520086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization of amorphous indomethacin by co-grinding in a ternary mixture.
    Watanabe T; Ohno I; Wakiyama N; Kusai A; Senna M
    Int J Pharm; 2002 Jul; 241(1):103-11. PubMed ID: 12086726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS).
    Agarwal V; Siddiqui A; Ali H; Nazzal S
    Int J Pharm; 2009 Jan; 366(1-2):44-52. PubMed ID: 18832019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin.
    Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
    Eur J Pharm Biopharm; 2016 Dec; 109():140-148. PubMed ID: 27746228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical approach to prepare solid dispersion drug product using spherical silicate.
    Nagane K; Kimura S; Ukai K; Ogawa N; Yamamoto H
    Int J Pharm; 2014 Nov; 475(1-2):364-71. PubMed ID: 25131150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid self-microemulsifying drug delivery system of ritonavir.
    Deshmukh A; Kulkarni S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin-omeprazole as therapeutic hybrids? Salt and co-amorphous systems enhancing physicochemical and pharmacological properties.
    Nascimento ALCS; Martins ICB; Spósito L; Morais-Silva G; Duarte JL; Rades T; Chorilli M
    Int J Pharm; 2024 Mar; 653():123857. PubMed ID: 38281693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
    Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
    Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.